Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01494792
Other study ID # CS-0142-02
Secondary ID
Status Terminated
Phase N/A
First received December 15, 2011
Last updated October 5, 2012
Start date November 2011
Est. completion date August 2012

Study information

Verified date October 2012
Source Quidel Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

The purpose of this study is to demonstrate the ability of the Sofia Strep A FIA test and Sofia Analyzer to accurately detect a throat swab specimen for the presence or absence of Group A Streptococcus when compared to culture.


Recruitment information / eligibility

Status Terminated
Enrollment 2090
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender Both
Age group 3 Years and older
Eligibility Inclusion Criteria:

- Presence of sore throat

- Redness of the posterior pharyngeal wall

- Tonsillar exudate

- Tonsillar swelling

- Tender anterior cervical adenopathy

- Fever, > 38º C (100.4ºF) at presentation or within past 24 hours

Other symptoms that may be present, in addition to above symptoms for GAS:

- Rash, typical of scarlet fever

- Abnormal tympanic membranes

- Palatal petechiae

Exclusion Criteria:

- Subjects treated with antibiotics currently or within the previous week (7 days) are not to be included in this study.

- At clinical sites requiring informed consent, unable to understand and consent to participation; for minors this includes parent or legal guardian.

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
In Vitro Diagnositc aid for diagnosis


Locations

Country Name City State
United States Montrose Family Practice Akron Ohio
United States La Costa Pediatrics Carlsbad California
United States Children's Memorial Hospital Chicago Illinois
United States Santo Nino Medical Clinic Panorama City California
United States Twelve Corners Pediatrics Rochester New York
United States La Jolla Pediatrics San Diego California
United States Teena Hughes, MD Tampa Florida
United States Advanced Pediatrics Vienna Virginia

Sponsors (1)

Lead Sponsor Collaborator
Quidel Corporation

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT02534987 - Integrated Clinical Prediction Rules: Bringing Evidence to Diverse Primary Care Settings N/A
Recruiting NCT01561703 - Comparing Healthcare Utilization Between Adenotonsillectomy Patients With and Without Postoperative Antibiotic Use N/A
Suspended NCT03907449 - Preview Rapid Strep A Test Method Comparison Study
Completed NCT01441479 - Strep A Fluorescent Immunoassay and Analyzer Field Study N/A
Not yet recruiting NCT06380270 - Safety and Human Tolerance of Oral Probiotic Streptococcus Salivarius K12 N/A
Completed NCT03361163 - Controlled Human Infection for Vaccination Against Streptococcus Pyogenes Phase 1
Enrolling by invitation NCT04084977 - Dopaminergic Receptors in Sydenham's Chorea
Recruiting NCT01491776 - Evaluation of the IND One Step Strep A Rapid Test vs. Culture N/A